- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on First Ray Dorsiflexion in Australia
Total 19 results
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationUnited States, Australia
-
Melbourne HealthStanley Medical Research InstituteCompletedFirst Episode PsychosisAustralia
-
Royal North Shore HospitalUniversity of SydneyRecruitingLung Cancer | Markerless Image Guidance | Intrafraction Kolovoltage X-ray ImagingAustralia
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Stryker Australia Pty Ltd.Not yet recruitingArthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA))Australia
-
Hutchison Medipharma LimitedCompletedRheumatoid Arthritis (RA)Australia
-
European Organisation for Research and Treatment...RecruitingFirst Progression of GlioblastomaNetherlands, Austria, Germany
-
AmgenRecruitingAdvanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C MutationUnited States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
-
C. R. BardCompletedPeripheral Vascular Disease | Venous Disease | May-Thurner Syndrome | Iliofemoral Occlusive DiseaseUnited States, Australia, Germany, Ireland, Netherlands, Spain, United Kingdom
-
Optimed Medizinische Instrumente GmbHCompletedPost-thrombotic Syndrome | Iliac Vein Compression SyndromeSwitzerland, Austria, Germany, Netherlands
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
Bristol-Myers SquibbCompletedRheumatoid Arthritis (RA)United States, Australia, Mexico, South Africa
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
Bristol-Myers SquibbCompletedRheumatoid Arthritis (RA)Italy, Korea, Republic of, Mexico, Taiwan, United States, Chile, France, Poland, United Kingdom, Argentina, Belgium, Ireland, Germany, Netherlands, Canada, India, Russian Federation, Turkey, Australia, South Africa, Brazil, Hungary, Per... and more
-
AbbVieCompletedRheumatoid Arthritis (RA)United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Romania, Russian... and more
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
AbbVieActive, not recruitingRheumatoid Arthritis (RA)Argentina, Australia, Austria, Belgium, France, Germany, Greece, Ireland, Israel, Italy, Kuwait, Mexico, Russian Federation, Saudi Arabia, Spain, Switzerland, Taiwan, United Arab Emirates, Uruguay
-
AbbVieTerminatedRheumatoid Arthritis (RA)United States, Australia, Canada, Czechia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Puerto Rico, Russian Federation, Slovakia, Spain, Taiwan, Turkey, Ukraine
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain